Anna Raciborska
Clinical trials sponsored by Anna Raciborska, explained in plain language.
-
New hope for kids with rare immune disease: trametinib trial launched
Disease control Recruiting nowThis study looks at how to best use the drug trametinib in children with histiocytosis, a rare disease where immune cells build up and cause damage. It is for kids whose disease did not respond to standard treatments or who do not have the BRAF gene change. The goal is to find th…
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
New imaging and DNA test could transform Kids' cancer care
Knowledge-focused Recruiting nowThis study aims to improve how doctors diagnose and track histiocytosis, a rare disease that causes cell overgrowth, in children under 18. Researchers will use PET-CT scans with a special tracer and check tumor DNA in the blood to see if these methods can detect the disease earli…
Phase: PHASE3 • Sponsor: Anna Raciborska • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC